Last reviewed · How we verify
SHR-1701；Capecitabine；Oxaliplatin
SHR-1701；Capecitabine；Oxaliplatin is a Small molecule drug developed by Suzhou Suncadia Biopharmaceuticals Co., Ltd.. It is currently in Phase 2 development.
At a glance
| Generic name | SHR-1701；Capecitabine；Oxaliplatin |
|---|---|
| Sponsor | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer (PHASE2)
- SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis (PHASE2)
- PD1/TGFβ In Combination With EZH2 And Chemotherapy For First - Line Treatment Of Gastric Cancer (PHASE2)
- Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma (NA)
- A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRC (PHASE2, PHASE3)
- Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping (PHASE2)
- SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SHR-1701；Capecitabine；Oxaliplatin CI brief — competitive landscape report
- SHR-1701；Capecitabine；Oxaliplatin updates RSS · CI watch RSS
- Suzhou Suncadia Biopharmaceuticals Co., Ltd. portfolio CI
Frequently asked questions about SHR-1701；Capecitabine；Oxaliplatin
What is SHR-1701；Capecitabine；Oxaliplatin?
SHR-1701；Capecitabine；Oxaliplatin is a Small molecule drug developed by Suzhou Suncadia Biopharmaceuticals Co., Ltd..
Who makes SHR-1701；Capecitabine；Oxaliplatin?
SHR-1701；Capecitabine；Oxaliplatin is developed by Suzhou Suncadia Biopharmaceuticals Co., Ltd. (see full Suzhou Suncadia Biopharmaceuticals Co., Ltd. pipeline at /company/suzhou-suncadia-biopharmaceuticals-co-ltd).
What development phase is SHR-1701；Capecitabine；Oxaliplatin in?
SHR-1701；Capecitabine；Oxaliplatin is in Phase 2.